Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD)

CUSIP: 185063104

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
76,991,404
Total 13F shares
13,768,135
Share change
-1,732,202
Total reported value
$17,898,695
Put/Call ratio
0.57%
Price per share
$1.30
Number of holders
49
Value change
-$2,355,975
Number of buys
18
Number of sells
24

Quarterly Holders Quick Answers

What is CUSIP 185063104?
CUSIP 185063104 identifies CLSD - Clearside Biomedical, Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) as of Q2 2024

As of 30 Jun 2024, Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) was held by 49 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,768,135 shares. The largest 10 holders included VANGUARD GROUP INC, Rosalind Advisors, Inc., ARMISTICE CAPITAL, LLC, Carmignac Gestion, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, Assenagon Asset Management S.A., STATE STREET CORP, and FIRST MANHATTAN CO. LLC.. This page lists 49 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.